Dexamethasone Sodium Phosphate%2C Lidocaine Hydrochloride%2C Mar + Ketoconazole Interaction
Unknowninteraction on record
Description
Coadministration of a selective and potent inhibitor of CYP3A4, ketoconazole (100 mg bid for 2 days with ropivacaine infusion administered 1 hour after ketoconazole) caused a 15% reduction in in vivo plasma clearance of ropivacaine.
Source: FDA drug label - dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine